COMPANY

Ionetix

Location: Lansing, MI · source · Oct 12, 2026

Profile checked Oct 10, 2026

Keywords: Myocardial Ischemia Coronary Disease Coronary Artery Disease Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases

$30.0MRaised (2 yrs)1Trials (company is sponsor)

Timeline

Apr 21, 2026 Raise Private equity round: $30M (total, as published), announced Apr 21, 2026. Source: company's own press page. source ↗
Jun 20, 2025 Partnership Partnership / licensing announced Jun 20, 2025. Source: company's own press page. source ↗
Sep 14, 2020 Trial start —: Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP) source ↗

Funding

Raised: $30.0M. Last 2 years.

Apr 21, 2026 Private equity round: $30M (total, as published), announced Apr 21, 2026. Source: company's own press page. source ↗
Jun 20, 2025 Partnership / licensing announced Jun 20, 2025. Source: company's own press page. source ↗

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT04343209	Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)	Not listed	Completed	Sep 14, 2020	Aug 16, 2024 (actual)